We are delighted to share that we are back with our latest edition of the o2h Kickstarter: ‘Innovate America’, designed to support biotech startups based in the USA who are working on innovative and novel drug science.
|
|
Since 2022, o2h Discovery has been running the o2h Kickstarter Competition to support early-stage biotech companies in drug discovery. We've awarded over 20 startups world-wide including Origami Therapeutics, Sevenless Therapeutics, Psylo, Monash University, to name a few, offering vital chemistry/biology resources that have helped them achieve key milestones in their drug discovery and development.
Read on to learn more about our newest edition and check your eligibility to apply…
Kind Regards,
The Team @o2h Discovery
|
|
|
About the o2h Kickstarter: Innovate America
|
|
|
|
The o2h Kickstarter: Innovate America competition is designed to provide a chemistry boost to USA-based small molecule-focused biotechnology companies that have raised initial funding and need to supercharge their chemistry efforts to meet their next milestone. Winners will receive a cost-effective, dedicated team of six experienced o2h Discovery chemists and trainees, along with end-to-end project management support to generate the chemical matters required for their project milestones. Despite o2h's broader capabilities in Med Chem, ADME, and Biology Screening (in the UK and India), the goal is to keep the process straightforward and accessible.
|
|
Our previous US Kickstarter competitions benefited companies like Palm Therapeutics, Galilei Bioscience, and Synprox. We are delighted to be back with our newest version of this award to support innovative early-stage biotech companies working on novel drug discovery programs that can ultimately benefit human health.
To read more, please visit - o2h.com/o2h-kickstarter-innovate-america/
|
|
|
Some of the Winners of Earlier Kickstarter Editions
|
|
This is an opportunity for you to 'turbocharge your biotech startup with a chemistry boost!’ and take your novel drug discovery project to the next level with o2h Discovery’s support and expertise.
|
|
If you believe this opportunity could benefit your biotech network, we encourage you to share it with them.
|
|
|
About o2h Discovery: Overview & Capabilities
|
|
Founded in 2005, o2h Discovery is a Contract Research Organization with an integrated drug discovery platform, operating from its state-of-the-art research center in India and The Mill SciTech Park in Cambridge, UK.
Our in-house capabilities span the entire drug discovery process, from hit-to-lead optimization through to patent and IND filing. From our cutting-edge biotechnology incubator, we excel in discovery chemistry, biology, ADME, pharmacology, and the ongoing project management of pre-clinical development. Additionally, we have expanded our expertise into emerging areas such as Targeted Protein Degradation, LNPs, and assay development for ChamelogK, Integrin, Psychedelics, and more.
Read more on our website - www.o2hdiscovery.co
|
|
Copyright © 2024 o2h group, All rights reserved.
You are connected with o2h discovery with regards to chemistry and biology services and related..
Our mailing address is:
o2h group
The Mill Scitech Park, Hauxton House
Mill Lane, Hauxton
Cambridge, Cambridgeshire CB22 5HX
United Kingdom
Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.
|
|
|
|
|
